Thursday, July 23, 2009

Swine flu shots to boost Baxter:,0,3826525.story

Company reports 2nd-quarter profit increased by 13%, 2009 forecast raised
By Bruce Japsen | Tribune reporter July 17, 2009

International demand for a swine flu vaccine is developing into a boon for Baxter International Inc.
... On a day the Deerfield-based medical-product giant reported a 13 percent boost in second-quarter profit, Chairman and Chief Executive Robert Parkinson said the company's plant in the Czech Republic was running at capacity as it fills orders for 80 million dosages from five countries.
...Baxter has all the work it can handle and expects production of vaccines to combat the H1NI swine flu to continue indefinitely, particularly as strains mutate, Parkinson said.
..."There will be demand for whatever we will be able to produce," Parkinson told Wall Street analysts on an earnings conference call Thursday morning. 
...Baxter said it would begin shipping dosages of a swine flu vaccine worldwide by the end of July. Baxter could reap $30 million to $40 million in revenue from H1N1 contracts.

No comments:

Post a Comment